Biotech Biotech November 5, 2024 STAT Plus: Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit
Biotech Biotech November 5, 2024 STAT Plus: Patient dies in Beam Therapeutics trial of CRISPR sickle cell treatment